Uludağ Üniversitesi Tıp Fakültesi
Tıp Tarihi ve Etik Anabilim Dalı
 

M. MURAT CIVANER, MD PhD                                                                                    Türkçe


 

Professor
Uludag University School of Medicine
Department of Medical Ethics and History of Medicine
Bursa, Turkey

mcivaner@gmail.com

 
   
   

I have graduated from School of Medicine, Uludag University in 1992. Received a PhD degree in ‘Public Health’ (Dokuz Eylul University, 1999), and a PhD degree in ‘Medical Ethics and History of Medicine’ (Ankara University, 2006).

Currently working as a professor of Medical Ethics and History of Medicine at Uludag University School of Medicine in Bursa, Turkey. My professional duties include teaching, ethics consultation, and research. I am teaching medical ethics and history of medicine to medical students, to our master and PhD students, and also research ethics to future researchers.

I am a member of Patient Rights Committee in our university hospital, Uludag University Centre for Health, Practice and Research, which handles patient complaints weekly.

I also work in the Hospital Ethics Committee, established for case review, guideline development, and training physicians. I have been honoured by Hans-Joachim Schwager - Prize for Clinical Ethics in 2017 for recognizing my efforts for the development of clinical ethics consultation in our university hospital, and establishing a Hospital Ethics Committee.
http://www.clinical-ethics.org/hans-joachim-schwager-award/2017-singapore/

I serve as an “Official Advisor” to World Medical Association since the term of 2016-7.

I am trying to contribute to the development of Bioethics, by emphasizing the right to health and professional values as fundamental guides.

The areas of interest include: Artificial intelligence in medicine; Big Data in healthcare; Healthcare workers' relationships with medical industry; Effects of healthcare policies on professional values and right to health; Inequities in health and right to health; Allocation of resources; Clinical ethics; The limits of duty to care; End-of-life care; Organ transplantation; Research ethics; Enhancement of human-being; Ethical problems related to genetics; Disaster bioethics.

My current researches are exploring the questions of:

- What do medical students think on the possible influences of artificial Intelligence in medicine? What are the risks and opportunities they perceive? Do they feel ready? On which topics they would like to be trained?

- What are the opinions of medical students on conscientious objection in medicine? Where do they draw the limits and what are their reasons? Are their reasons justifiable?

- What is the level of evidence about efficiency and safety of traditional, complementary, and alternative medicine treatments?

- What do patient relatives think about end of life decisions of physicians working in ICUs? What are their expectations from medicine regarding their terminally-ill patients in ICU?
 

   
 
   
  Professional memberships

National

  • Turkish Medical Association (1992 - present)
  • Turkish Bioethics Society (1997 - present)
  • Society for Development of Medical Education (2000 - present)
  • Society of Public Health Specialists (2000 – present)
  • Foundation of Turkish History of Medicine (2002 - present)
  • Society of Medical Ethics and Medical Law (2005 - present)

International

  • World Medical Association - Official Advisor to Medical Ethics Committee, since the term of 2016-7
  • International Association of Bioethics (2002 - present)
  • Health Action International (2005 - present)
  • Healthy Skepticism (2005 - present)
  • The European Society for Philosophy of Medicine and Healthcare (2009 – present)
  • International Association for Education in Ethics (2011 – present)
   
 
   
  Awards
  • Hans-Joachim Schwager Prize for Clinical Ethics, 2017
   
 
   
 

Selected publications

  • Civaner MM, Uncu Y, Bulut F, Chalil EG, Tatlı A. Artificial intelligence in medical education: a cross-sectional needs assessment. BMC Medical Education. 2022;22(1):772.
  • Civaner MM. A follow-up study on the effects of an educational intervention against pharmaceutical promotion. PLoS ONE, 2020;15(10): e0240713.
  • Civaner M, Vatansever K, Pala K. Ethical Problems in an Era Where Disasters Have Become a Part of Daily Life: A Qualitative Study of Healthcare Workers in Turkey. PLoS One. 2017 Mar 20;12(3):e0174162.
  • Civaner M, Balcioglu H, Vatansever K. Medical students’ opinions about commercialisation of healthcare - a cross sectional survey. Journal of Bioethical Inquiry 2016;13:261-70.
  • Önal G, Civaner M. For what reasons do patients file a complaint? A retrospective study on Patient Rights Units’ registries. Balkan Medical Journal 2015;32:17-22.
  • Civaner M. Health-care reform in Turkey: far from perfect. The Lancet 2014;383(9911):26.
  • Civaner M. Sale strategies of pharmaceutical companies in a “pharmerging” country: the problems will not improve if the gaps remain. Health Policy, 2012;106(3):225-32.
  • Civaner M. “Transforming” our health by privatisation. British Medical Journal, 2011; 342:d1959.
  • Civaner M. “Healthcare-caused harm”, instead of “Malpractice””. Turkish Archives of Pediatrics 2011;46:6-11.
  • Alpinar Z, Civaner M, Örs Y. Rationing healthcare: should life-style be used as a criterion? Anatolian Journal of Cardiology 2010;10:367-71.
  • Sarıkaya Ö, Civaner M, Vatansever K. Exposure of medical students to pharmaceutical marketing in primary care settings: frequent and influential. Advances in Health Sciences Education 2009;14(5):713-24.
  • Civaner M, Sarıkaya Ö, Balcıoğlu H. Medical ethics in residency training. Anatolian Journal of Cardiology 2009 Apr;9(2):132-138. (in Turkish)
  • Civaner M. How does the institutional consciousness of Bioethics influence its agenda? Turkiye Klinikleri J Med Sci 2008;28:727-735. (in Turkish)
  • Civaner M. A proposal for prevention of ethical problems derived from drug promotion: National Network of Drug Information. Turkish Journal of Psychiatry 2008;19(3):310-7.
  • Civaner M, Sarikaya O, Alici SU, Bozkurt G. Exposing nursing students to the marketing methods of pharmaceutical companies. Nursing Ethics 2008;15(3):396-410.
  • Civaner M, Arda B. Can "presumed consent" justify the duty to treat infectious diseases? An analysis. BMC Infectious Diseases 2008;8:29.
  • Civaner M, Arda B. Do patients have responsibilities in a free-market system? A personal perspective. Nursing Ethics 2008;15(2):263-73.
  • Civaner M. Argument analysis in moral philosopy. In: Medikal Etik - 6. Yüce Yayım:İstanbul, 2006:119-31. (book chapter - in Turkish)
  • Kavas MV, Civaner M. “Globalization” and metamorphosis of healthcare services in Turkey. Analecto Historica Medica. 2006;4:439-46.
  • Civaner M. How the technology influence our point of view about healthcare? Toplum ve Hekim, 2005;20(4):279-84. (in Turkish)
  • Ozkara E, Hanci H, Civaner M, Yorulmaz C, Karagoz M, Mayda AS, Goren S, Kok AN. Turkey’s physicians’ attitudes toward euthanasia: a brief research report. OMEGA Journal of Death and Dying, 2004;49(2):109-15.
  • Civaner M. End of life as an important ethical problem field. Toplum ve Hekim, 2003;18(2):148-51. (in Turkish)
  • Oguz Y, Miles SH, Buken N, Civaner M. End of life care in Turkey. Cambridge Quarterly of Healthcare Ethics,2003;12(3):279-84.
  • Civaner M, Terzi C. Right to self-determination: Informed consent. Ulusal Cerrahi Dergisi, 2001;17(2):82-91. (in Turkish)
  • Civaner M, Demiral Y, Şemin S, Amato Z. Knowledge and opinions of faculty of Dokuz Eylul University School of Medicine about publication ethics. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, 2000;14(2):161-9. (in Turkish)

Postal address
Uludag Universitesi Tip Fakultesi
Tip Tarihi ve Etik AD
Gorukle, 16059
Bursa, Turkey

T: +90.224.295 4272
mcivaner@gmail.com